Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-20

FDA Approved: CIPRO HC — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for CIPRO HC (ciprofloxacin hydrochloride and hydrocortisone) submitted by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CIPRO HC (ciprofloxacin hydrochloride and hydrocortisone)

Snippet

SUPPL AP for CIPRO HC (CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE)